The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Identification of drug-side effect association via multiple information integration with centered kernel alignment
Abstract
In medicine research, drug discovery aims to develop a drug to patients who will benefit from it and try to avoid some side effects. However, the tradition experiment is time consuming and expensive. In recent years, computational approaches provide many effective strategies to deal with this issue. In fact, the known associations between drugs and side-effects are less than unknown associations, thus it can be seen as an imbalance classification problem. Although several classification methods have been developed to predict drug-side effect associations, the performance of predictors could also be further improved. In this paper, we propose a novel predictor of drug-side effect associations. First, we construct multiple kernels from drug space and side-effect space, respectively. Then, these corresponding kernels are linear weighted by optimized Centered Kernel Alignment-based Multiple Kernel Learning (CKA-MKL) algorithm in two different spaces. At last, Kronecker Regularized Least Squares (Kronecker RLS) is employed to fuse drug kernel and side-effect kernel, further identify drug-side effect associations. Compared with many existing methods, our proposed approach achieves better results on three benchmark datasets of drug side-effect associations. The values of Area Under the Precision Recall curve (AUPR) are 0.672, 0.679 and 0.675 on Pauwels’s dataset, Mizutani’s dataset and Liu’s dataset, respectively. The AUPRs are improved by at least 0.012, 0.013 and 0.014 on three different datasets. Experimental results show that our method has outstanding performance among other excellent approaches on identifying drug-side effect associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
KEGG for representation and analysis of molecular networks involving diseases and drugs
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Adverse drug events: database construction and in silico prediction
Cheng, F., Li, W., Wang, X., Zhou, Y., Wu, Z., Shen, J., & Tang, Y. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci4000079 · Cited by 124
Cited by
The ethics of AI in health care: A mapping review
Morley, J., Machado, C. C. V., Burr, C., Cowls, J., Joshi, I., Taddeo, M., & Floridi, L. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113172 · Cited by 1,105
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Toward better drug discovery with knowledge graph
Zeng, X., Tu, X., Liu, Y., Fu, X., & Su, Y. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.09.003 · Cited by 229
Xuan, P., Sun, C., Zhang, T., Ye, Y., Shen, T., & Dong, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00459 · Cited by 100
The Debate on the Ethics of AI in Health Care: a Reconstruction and Critical Review
Morley, J., Machado, C., Burr, C., Cowls, J., Taddeo, M., & Floridi, L. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3486518 · Cited by 66
Metadata
- Authors
- Ding, Y., Tang, J., & Guo, F.
- Venue
- Neurocomputing
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 325
- Pages
- 211-224
- ISSN
- 0925-2312 (ISSN-L)
- OpenAlex
- W2896605526
- Cited by
- 221
- References
- 4
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.